A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...

This woman in her early 30s with an 11 year history of systemic lupus erythematosus (SLE) experienced a sudden disease ...

Lupus Awareness Month shines a spotlight on a disease that affects millions worldwide yet remains widely misunderstood. Lupus ...

This mysterious autoimmune disease presents with over 100 different symptoms, making diagnosis incredibly challenging for ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations (autoinjector, prefilled syringe, and single-dose vial) of ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations ...

Lupus warrior Reshma Ragoonath is continuing her campaign in the Cayman Islands to raise awareness of the autoimmune disease.

Kyleigh MacGregor plans her life five years at a time. MacGregor has lupus, an incurable disease in which her immune system ...

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...

Merck Presents Positive Phase 2 Data for Enpatoran Demonstrating Reduction in Disease Activity in Patients with Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE) with Active L ...

Lupus, also known as Systemic Lupus Erythematosus (SLE), is a chronic autoimmune disease where the body's immune system ...

WILLOW is a global, multicenter, randomized, placebo-controlled Phase 2 study evaluating three doses of enpatoran taken twice daily (25 mg, 50 mg and 100 mg) versus placebo plus standard of care (SoC) ...